| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Stanford University |
| Information provided by: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT00285870 |
Purpose
Dr. Sanger and the research team want to learn about upper extremity hypertonia (stiffness) in children and young adults with cerebral palsy. Specifically, they want to learn about ways to measure the stiffness in the joints of hypertonic arms. The information the research team will collect includes any physical exams or computer generated data about your arm movements.
| Condition | Intervention |
|
Dystonia Hypertonia |
Device: no intervention; observational study only |
| Genetics Home Reference related topics: | early-onset primary dystonia |
| MedlinePlus related topics: | Dystonia |
| Study Type: | Observational |
| Study Design: | Natural History, Cross-Sectional, Defined Population, Prospective Study |
| Official Title: | Quantification of Upper Extremity Hypertonia |
Eligibility
| Ages Eligible for Study: | 4 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Dystonia in at least one arm Age 4 to no upper limit -
Exclusion Criteria:
increased risk of participation botulinum toxin within 6 months
-
Contacts and Locations| Contact: Terence Sanger, MD, PhD | 6507362154 | sangeR@stanford.edu |
| United States, California | |||||
| Stanford University | Recruiting | ||||
| Stanford, California, United States, 94305-5235 | |||||
| Contact: Terence D Sanger, MD, PhD 650-736-2154 sanger@stanford.edu | |||||
| Contact: Terence Sanger 650 736-2154 sanger@stanford.edu | |||||
| Principal Investigator: Terence D Sanger, MD, PhD | |||||
| Stanford University |
| Principal Investigator: | Terence D Sanger, md,phd | Stanford University |
More Information
| Study ID Numbers: | UPPER EXTREMITY HYPERTONIA |
| First Received: | January 31, 2006 |
| Last Updated: | April 25, 2007 |
| ClinicalTrials.gov Identifier: | NCT00285870 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
